Kaustubh Bhardwaj et al. 2026. FUTURE CHALLENGES AND EMERGING SAFETY CONCERNS OF GLP-1 RECEPTOR AGONISTS, DUAL INCRETIN AGONISTS, AND SGLT2 INHIBITORS. Journal of Population Therapeutics and Clinical Pharmacology. 33, 2 (Jun. 2026), 963–981. DOI:https://doi.org/10.69980/mng8r305.